3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Sarcoma
2
Uterine Cervical Neoplasms
1
Skin Neoplasms
1
Neoplasm Metastasis
1
Leiomyosarcoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Specimen Handling
2
Semaxinib
2
tin etiopurpurin
1
pembrolizumab
1
montanide ISA 51
1
cc-486
1
atezolizumab
1
Tumor Necrosis Factor-alpha
1
Tissue Banks
1
SUB1 protein, human
1
Ritonavir
1
Radiosurgery
1
Quality of Life
1
Patient Reported Outcome Measures
1
Observation
1
Nelfinavir
1
Molecular Diagnostic Techniques
1
Mohs Surgery
1
Melphalan
1
Interleukin-2
1
Interleukin-12
1
Injections
1
Immunotherapy
1
Etoposide
1
Drug Therapy
1
Cyclophosphamide
1
Blood Specimen Collection
1
Biopsy
1
Biological Therapy
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Tissue Banks
×
Sarcoma
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled